1. Home
  2. TYRA vs RSKD Comparison

TYRA vs RSKD Comparison

Compare TYRA & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • RSKD
  • Stock Information
  • Founded
  • TYRA 2018
  • RSKD 2012
  • Country
  • TYRA United States
  • RSKD United States
  • Employees
  • TYRA N/A
  • RSKD N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • RSKD EDP Services
  • Sector
  • TYRA Health Care
  • RSKD Technology
  • Exchange
  • TYRA Nasdaq
  • RSKD Nasdaq
  • Market Cap
  • TYRA 844.2M
  • RSKD 743.4M
  • IPO Year
  • TYRA 2021
  • RSKD 2021
  • Fundamental
  • Price
  • TYRA $14.27
  • RSKD $4.79
  • Analyst Decision
  • TYRA Strong Buy
  • RSKD Hold
  • Analyst Count
  • TYRA 5
  • RSKD 7
  • Target Price
  • TYRA $31.20
  • RSKD $5.79
  • AVG Volume (30 Days)
  • TYRA 261.6K
  • RSKD 390.2K
  • Earning Date
  • TYRA 11-05-2025
  • RSKD 11-12-2025
  • Dividend Yield
  • TYRA N/A
  • RSKD N/A
  • EPS Growth
  • TYRA N/A
  • RSKD N/A
  • EPS
  • TYRA N/A
  • RSKD N/A
  • Revenue
  • TYRA N/A
  • RSKD $335,825,000.00
  • Revenue This Year
  • TYRA N/A
  • RSKD $6.28
  • Revenue Next Year
  • TYRA N/A
  • RSKD $9.78
  • P/E Ratio
  • TYRA N/A
  • RSKD N/A
  • Revenue Growth
  • TYRA N/A
  • RSKD 7.96
  • 52 Week Low
  • TYRA $6.42
  • RSKD $3.94
  • 52 Week High
  • TYRA $17.78
  • RSKD $6.00
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 49.37
  • RSKD 51.81
  • Support Level
  • TYRA $13.35
  • RSKD $4.58
  • Resistance Level
  • TYRA $15.38
  • RSKD $4.80
  • Average True Range (ATR)
  • TYRA 0.92
  • RSKD 0.12
  • MACD
  • TYRA -0.14
  • RSKD -0.01
  • Stochastic Oscillator
  • TYRA 35.37
  • RSKD 43.90

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

Share on Social Networks: